ARTICLE | Company News
Raptor Pharmaceuticals Corp., Washington University deal
November 13, 2006 8:00 AM UTC
RPTP licensed exclusive worldwide rights to the university's proteins and peptides derived from the mesoderm development (Mesd) gene sequence for therapeutic use in cancer and bone diseases. The Mesd ...